Genkyotex announced that Dr. Ursula M. Ney has resigned as chief executive officer and as a member of the Board of Directors effective September 30, 2015. Genkyotex's Board of Directors has promoted Elias Papatheodorou to the role of acting Chief Executive Officer and Dr. Philippe Wiesel to Executive Vice President and Chief Medical Officer. Mr. Papatheodorou joined Genkyotex in March 2015 as Chief Business Officer.

Mr. Papatheodorou has more than 20 years of experience with private and public biotechnology companies, as well as with The Coca-Cola Company and Philip Morris International. Philippe Wiesel joined Genkyotex in 2010 and has been responsible for all clinical development activities at the company.